Asian Spectator

Men's Weekly

.

Trio of 8½ Otto e Mezzo BOMBANA Chefs Present a Six-Michelin-Star Culinary Extravaganza at Galaxy Macau

Legendary Italian chef Umberto Bombana joins forces with the Executive Chefs of his Macau and Shanghai restaurants to celebrate the season of Australian Black Truffle and award-winning wine list at 8&...

Powerful STEM Robotics "Boson Kit" Starts Selling in Japan

TOKYO, Japan, Aug. 14, 2018/PRNewswire-Asianet/-- World-leading STEM hardware solution provider DFRobot announces to supply Boson Kit (https://www.dfrobot.com/boson) in Japan today, and its ...

Ten Most Crucial Events of the Decade: The Release of Special Forex Industry Analytics

KUALA LUMPUR, MALASIA - Media OutReach - 25 August 2021 - The international Forex broker OctaFX turns ten years old. This past decade culminates in 6.6 million Forex trading a...

Aeroflot Named China's Favourite International Airline for the...

MOSCOW, April 23, 2019 /PRNewswire-AsiaNet/ -- Aeroflot has been once again recognised as the Favourite International Airline in China. The prestigious award was given to Aeroflot for the th...

Quectel and Point One partnership creates highly affordable, s...

SAN FRANCISCO, Dec. 9, 2021 /PRNewswire-AsiaNet/ -- Quectel Wireless Solutions (https://quectel.com/), a global supplier of IOT modules and antennas, and Point One Navigation (https://pointo...

Zhonghua Gas Holdings Limited Announces Positive Profit Alert for 2019 First Quarter

HONG KONG, Apr 26, 2019 - (ACN Newswire) - Zhonghua Gas Holdings Limited (the "Company"; Stock Code: 8246) together with its subsidiaries (collective namely the "Group") today announces the...

Counting Down to Highly-Anticipated New Project: Tia Lee to Launch Her First-Ever Goodbye Princess Animation Series Tomorrow

HONG KONG SAR - Media OutReach - 10 November 2022 - Tia Lee, Asian fashion icon, pop singer, film and television actress, has posted a sensational countdown graphic series for three consecu...

FII 5th Anniversary Brings Together 250+ Leaders to Invest in ...

RIYADH, Saudi Arabia, Oct. 13, 2021 /PRNewswire-AsiaNet/ -- - The 5th Anniversary of the Future Investment Initiative will be held October 26 – 28 in the Saudi capital Riyadh under the...

Infinix NOTE 7: Powerful Features, Infinite Possibilities

NAIROBI, KENYA - Media OutReach - 23 July 2020 - Infinix, a premium online-driven smartphone brand designed for the young generations, and Infinix NOTE 7 which is a newes...

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 5, 2019 - (JCN Newswire) - Eisai Co., Ltd. announced today that the latest information on its in-house discovered and developed eribulin mesylate (halichondrin class microtubule dynamics inhibitor, product name: HALAVEN, "eribulin") will be presented during the 42nd San Antonio Breast Cancer Symposium (SABCS2019). The symposium will be held from December 10 through 14, 2019, in San Antonio, Texas in the United States.

Eisai to Present New Research on Eribulin (Halaven) at 42nd Annual San Antonio Breast Cancer Symposium

A total of five poster presentations will be given at this year's SABCS including the study results evaluating absolute lymphocyte count at the baseline with eribulin as a predictor of overall survival from the post-hoc analysis of two Phase III clinical studies of eribulin in patients with advanced or metastatic breast cancer.Eisai positions oncology as a key therapeutic area, and is aiming to discover revolutionary new medicines with the potential to cure cancer. Eisai will continue to create innovation in the development of new drugs based on cutting-edge cancer research, as it seeks to contribute further to addressing the diverse needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare providers.

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Neurology and Oncology.

In its medium-term business plan EWAY2025, Eisai is aiming to become a "Medico Societal Innovator" (a company that changes society through creating medicines and providing solutions), and is working on establishment of ecosystem platform business utilizing various data such as a large amount of clinical data, experiences, and know-how.

For more information about Eisai Co., Ltd., please visit https://www.eisai.co.jp.

Contact:Public Relations Department,
Eisai Co., Ltd.
+81-(0)3-3817-5120

Copyright 2019 JCN Newswire. All rights reserved. www.jcnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Cemas saat berulang tahun? Simak tip psikolog untuk hadapi ‘birthday blues’

DavideAngelini/ShutterstockUlang tahun biasanya jadi momen membahagiakan penuh dengan tawa, perayaan, dan hadiah. Namun, tak jarang menjelang ulang tahun, kita justru merasa sedih.Ulang tahun dapat me...

Kenapa calon pengantin perlu cek kesehatan sebelum menikah?

● Cek kesehatan pranikah merupakan pemeriksaan kesehatan bagi calon pengantin.● Prosedur ini bisa cegah penularan infeksi seksual hingga penyakit keturunan.● Sejumlah daerah menjadik...

Militerisme di media sosial: Bagaimana UU TNI mengancam kebebasan sipil di dunia siber

Anggota Brigif Para Raiders, pasukan khusus TNI, sedang melakukan latihan tempur dalam rangka memperingati HUT TNI, pada 10 Oktober 2020 di Malang.Oyek Vizual Studio/Shutterstock● UU TNI baru me...